Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis - NCT00884585- (Clinical Trial 287894)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy287894.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Bakersfield |
|
State:
|
|
CA |
| Zip Code: |
|
|
| Conditions: |
|
Atopic Conjunctivitis |
| Purpose: |
|
This study evaluates the efficacy and safety of Cyclosporine 0.010% eye drops in the
treatment of Atopic Keratoconjunctivitis (chronic and severe inflammation of the eye). The
study consists of a double-masked phase, and open-labeled phase, and an open-labeled
maintenance phase. For the first 3 months of the study, patients will receive either masked
Cyclosporine 0.010% eye drops or vehicle four times daily; for the next 6 months, patients
may receive open-labeled Cyclosporine 0.010% eye drops four times daily. At month 9,
patients who are in remission, will be re-randomized to receive either open-labeled
Cyclosporine 0.010% eye drops four times daily or twice daily
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Have a clinical diagnosis of Atopic Keratoconjunctivitis (chronic and severe
inflammation of the eye)
- Be on stable doses of your current AKC medications for at least 2 weeks
Exclusion Criteria:
- You have used contact lenses within 48 hours of Day 1 or think you may have to wear
contact lenses during the study
- You are pregnant, breastfeeding, or planning to become pregnant during the study
- You have used a calcineurin inhibitors (e.g. topical tacrolimus or topical
pimecrolimus) on or around your eyes including eyelids within 4 weeks |
|
|
|
| Study is available at: |
|
Bakersfield, CA
United States
Primary Contact:
Allergan Inc.
Email: clinicaltrials@allergan.com |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|